Tanimura & Antle Inc. is voluntarily recalling a single lot of romaine lettuce because it may be contaminated with Escherichia coli O157:H7 bacteria (E. Coli O157:H7). The affected product is limited to Tanimura & Antle Field Fresh Wrapped Single Head Romaine.
Category Archives: Food & Drug Recalls
Health Hazard Alert – Certain Sliced White Mushrooms May Contain Listeria Monocytogenes
Ciolino Produce was notified that our Highline 8 oz. packaged Sliced White Mushrooms may be contaminated with Listeria Monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea.
BI-LO Issues Recall on Southern Home Brand of Cranberry Nut Antioxidant Blend Trail Mix
Today BI-LO announced an immediate voluntary recall on Southern Home® Cranberry Nut Antioxidant Blend Trail Mix sold in the 16 oz. bag with a universal bar code (UPC) of 0788003039 and a best-by date of March 12, 2013. The product is being recalled in the states of Georgia, North Carolina, South Carolina and Tennessee due to a potential, undeclared presence of soy lecithin, which is a processed soy product.
Pure Hothouse Foods Inc, Announces a Voluntary Recall of Fresh Cut Grilling Trays Because of Possible Health Risk
Pure Hothouse Foods Inc. is voluntarily recalling a total of 1402 cases and 8,412 individually distributed units of fresh cut grilling trays, as listed below, with the Sell by dates of August 11th, 2012 through August 26, 2012 because they contain whole or sliced mushrooms which may be contaminated with Listeria monocytogenes.
FDA approves first generic Actos to treat type 2 diabetes
The U.S. Food and Drug Administration today approved the first generic version of Actos (pioglitazone hydrochloride) tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in adults with type 2 diabetes.
Covidien Initiates a Voluntary Recall of DGPHP RFA High-Power Single Use Grounding Pads and Cool-tip™ RFA Electrode Kits that Contain DGPHP RFA High-Power Single Use Grounding Pads
Covidien today announced that it is conducting a voluntary recall of certain production lots of the DGPHP RFA high-power single use grounding pads and Cool-tip™ RFA electrode kits that contain DGPHP RFA high-power single use grounding pads.
FDA recommends X-ray or other imaging on implanted heart defibrillators with St. Jude Medical Riata leads to help guide treatment
The U.S. Food and Drug Administration recommended today that patients who have implantable heart defibrillators with Riata and Riata ST leads, manufactured by St. Jude Medical, should have X-rays or other imaging alternatives to check for abnormalities in the insulation surrounding the lead, which is a wire attached to the device that is inserted into the heart.
Hospira Announces A Nationwide Recall Of Three Lots Of Propofol Due To Glass Vial Defect
Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today announced a nationwide recall of three lots of Propofol Injectable Emulsion, 1%, 1g/100 mL, due to visible particles embedded in the glass to the user level. There may be potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
Hospira Announces A Nationwide Voluntary Recall Of One Low Of Hydromorphone Hydrochloride Injection 2 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject, That May Contain More Than The Intended Fill Volume
Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary user level recall of one lot of Hydromorphone Injection, USP, 2 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1312-30 , due to a reported complaint of a single Carpuject containing more than the 1 mL labeled fill volume.
FDA warns of risk of death from codeine use in some children following surgeries
The U.S. Food and Drug Administration today issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils (tonsillectomy) and/or adenoids (adenoidectomy).